Sotabase

Career

· Gemeente en
· Projectmedewerker, KU Leuven
· Research Support Staff, KU Leuven

Publications (12)

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
British Journal of Cancer · 2002
533
cited
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Nature Medicine · 2022
397
cited
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
British Journal of Cancer · 2002
269
cited
Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459
Allergy. European Journal of Allergy and Clinical Immunology · 2014
136
cited
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★
Journal of Neuro-Oncology · 2006
115
cited
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen
British Journal of Cancer · 1999
73
cited
EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.
New England Journal of Medicine · 2022
44
cited
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
2022
43
cited
Tumour marker levels during marimastat therapy
The Lancet · 1996
11
cited
LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study
Open Forum Infectious Diseases · 2019
10
cited
The Potent and Selective CRTH2 Antagonist OC000459 Is Effective In The Treatment Of Eosinophilic Asthma When Given Once Daily
2014
1
cited
TUMOUR MARKER LEVELS DURING MARIMASTAT THERAPY. AUTHORS' REPLY
1996
Sotabase
Inès Baillet | Researcher Profile | Sotabase | Sotabase